Dergiler / Journal of Experimental and Clinical Medicine / 2017 / Cilt: 34 - Sayı: 4

Association of gamma-glutamyl transpherase activity with electrocardiographic indicators in coronary artery disease patients

Sayfa
235–240
Yayın Tarihi
2019-10-10
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These results indicate that there might be an increased risk of arrhythmias especially the atrial fibrillation in this patient population.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:<!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;} @font-face {font-family:"Arial Unicode MS"; panose-1:2 11 6 4 2 2 2 2 2 4; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:-134238209 -371195905 63 0 4129279 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-fareast-font-family:"Times New Roman";} p.Body1, li.Body1, div.Body1 {mso-style-name:"Body 1"; mso-style-unhide:no; mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; mso-outline-level:1; font-size:12.0pt; mso-bidi-font-size:10.0pt; font-family:Helvetica; mso-fareast-font-family:"Arial Unicode MS"; mso-bidi-font-family:"Times New Roman"; color:black; text-underline:black;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page WordSection1 {size:612.0pt 792.0pt; margin:72.0pt 90.0pt 72.0pt 90.0pt; mso-header-margin:36.0pt; mso-footer-margin:36.0pt; mso-paper-source:0;} div.WordSection1 {page:WordSection1;} --> <!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;} @font-face {font-family:"Arial Unicode MS"; panose-1:2 11 6 4 2 2 2 2 2 4; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:-134238209 -371195905 63 0 4129279 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-fareast-font-family:"Times New Roman";} p.Body1, li.Body1, div.Body1 {mso-style-name:"Body 1"; mso-style-unhide:no; mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; mso-outline-level:1; font-size:12.0pt; mso-bidi-font-size:10.0pt; font-family:Helvetica; mso-fareast-font-family:"Arial Unicode MS"; mso-bidi-font-family:"Times New Roman"; color:black; text-underline:black;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page WordSection1 {size:612.0pt 792.0pt; margin:72.0pt 90.0pt 72.0pt 90.0pt; mso-header-margin:36.0pt; mso-footer-margin:36.0pt; mso-paper-source:0;} div.WordSection1 {page:WordSection1;} --> Gamma-glutamyl transpherase (GGT) plays an important role in atherogenesis through its activity in oxidative processes, which has been demonstrated in clinical studies.
📊
Temel Bulgular & Veri:We examined patients (n = 254, 174 males, mean age 62 ± 8) diagnosed with coronary artery disease on the basis of clinical and angiographic findings.
💡
Sonuç & Katkı:These results indicate that there might be an increased risk of arrhythmias especially the atrial fibrillation in this patient population.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Gamma-glutamyl transpherase · Atherosclerosis · P-wave dispersion

Abstract

<!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;} @font-face {font-family:"Arial Unicode MS"; panose-1:2 11 6 4 2 2 2 2 2 4; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:-134238209 -371195905 63 0 4129279 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-fareast-font-family:"Times New Roman";} p.Body1, li.Body1, div.Body1 {mso-style-name:"Body 1"; mso-style-unhide:no; mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; mso-outline-level:1; font-size:12.0pt; mso-bidi-font-size:10.0pt; font-family:Helvetica; mso-fareast-font-family:"Arial Unicode MS"; mso-bidi-font-family:"Times New Roman"; color:black; text-underline:black;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page WordSection1 {size:612.0pt 792.0pt; margin:72.0pt 90.0pt 72.0pt 90.0pt; mso-header-margin:36.0pt; mso-footer-margin:36.0pt; mso-paper-source:0;} div.WordSection1 {page:WordSection1;} --> <!-- /* Font Definitions */ @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;} @font-face {font-family:"Arial Unicode MS"; panose-1:2 11 6 4 2 2 2 2 2 4; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:variable; mso-font-signature:-134238209 -371195905 63 0 4129279 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-fareast-font-family:"Times New Roman";} p.Body1, li.Body1, div.Body1 {mso-style-name:"Body 1"; mso-style-unhide:no; mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; mso-outline-level:1; font-size:12.0pt; mso-bidi-font-size:10.0pt; font-family:Helvetica; mso-fareast-font-family:"Arial Unicode MS"; mso-bidi-font-family:"Times New Roman"; color:black; text-underline:black;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page WordSection1 {size:612.0pt 792.0pt; margin:72.0pt 90.0pt 72.0pt 90.0pt; mso-header-margin:36.0pt; mso-footer-margin:36.0pt; mso-paper-source:0;} div.WordSection1 {page:WordSection1;} --> Gamma-glutamyl transpherase (GGT) plays an important role in atherogenesis through its activity in oxidative processes, which has been demonstrated in clinical studies. The connection between serum GGT activity and noninvasive arrhythmia indicators in patients with coronary artery disease (CAD) is investigated in the present study. We examined patients (n = 254, 174 males, mean age 62 ± 8) diagnosed with coronary artery disease on the basis of clinical and angiographic findings. All patient data were assessed, including serum GGT activity, biochemical measurements, and demographic and electrocardiographic features. A positive correlation was found between GGT levels and P-wave dispersion (r = 0.299, p < 0.0001); however, there was a negative correlation between GGT and ejection fraction (r = 0.216, p < 0.001). On the other hand, no correlation was found between GGT and the following: Sokolow-Lyon voltage, Cornell voltage, Cornell product, corrected QT, and QT dispersion (p values are 0.728, 0.892, 0.551, 0.069, and 0.146, respectively). When the patients were grouped according to gender, a significant association of GGT with P-wave dispersion and ejection fraction was observed in both of the groups. Nonetheless, a significant correlation between GGT and QTc was only found in the female group. In this study, we found that increased GGT activity was correlated with P-wave dispersion. These results indicate that there might be an increased risk of arrhythmias especially the atrial fibrillation in this patient population.

🔖

Bu Makaleye Atıf Yap

MERİC, M., ÇOKSEVİM, M., DEMİRCAN, S., SOYLU, K., YUKSEL, S. (2019). Association of gamma-glutamyl transpherase activity with electrocardiographic indicators in coronary artery disease patients. Journal of Experimental and Clinical Medicine, Cilt: 34 - Sayı: 4, 235–240. https://ajindex.com/articles/678282

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Alonso, A., Misialek, J.R., Amiin, M.A., Hoogeveen, R.C., Chen, L.Y., Agarwal, S.K., Loehr, L.R., Soliman, E.Z., Selvin, E., 2014. Circulating levels of liver enzymes and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities cohort. Heart. 100(19), 1511-1516.
  2. Aviles, R.J., Martin, D.O., Apperson-Hansen, C., Houghtaling, P.L., Rautaharju, P., Kronmal, R.A., Tracy, R.P., Van Wagoner D.R., Psaty, B.M., Lauer M.S., Chung, M. K., 2003. Inflammation as a risk factor for atrial fibrillation. Circulation. 108(24), 3006-3010.
  3. Bradley, R.D., Fitzpatrick, A.L., Jacobs, D.R., Lee, D.H., Jenny, N.S., Herrington, D., 2014. Associations between γ-glutamyltransferase (GGT) and biomarkers of atherosclerosis: the multi-ethnic study of atherosclerosis (MESA). Atherosclerosis. 233(2), 387-393.
  4. Cameron, A., Schwartz, M.J., Kronmal, R.A., Kosinski, A.S., 1988. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). The Am. J. Cardiol. 61(10), 714-717.
  5. Cheitlin, M.D., Alpert J.S., Armstrong, W.F., Aurigemma, G.P., Beller G.A., Bierman, F.Z., Davidson, T.W., Davis, J.L., Douglas, P.S., Gillam, L.D., 1997. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Circulation. 95:1686-1744.
  6. Chung, M.K., Martin, D.O., Sprecher, D., Wazni, O., Kanderian, A., Carnes, C.A., Bauer J.A., Tchou P.J., Niebauer M.J., Natale A., Van Wagoner D.R., 2001. C-reactive protein elevation in patients with atrial arrhythmias inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 104(24), 2886-2891.
  7. Dilaveris, P.E., Gialafos, E.J., Andrikopoulos, G.K., Richter, D.J., Papanikolaou, V., Poralis, K., Gialafos, J.E., 2000. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin. Electrophysiol. 23(3), 352-358.
  8. Emdin, M., Passino, C., Michelassi, C., Titta, F., L'abbate, A., Donato, L., Pompella A., Paolicchi, A., 2001. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur. Heart J. 22(19), 1802-1807.
  9. Emdin, M., Pompella, A., Paolicchi, A. 2005. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease triggering oxidative stress within the plaque. Circulation. 112(14), 2078-2080.
  10. Haddad, A.H., Prchkov, V.K., Dean, D.C., 1978. Chronic atrial fibrillation and coronary